company background image
ZTS

Zoetis NYSE:ZTS Stock Report

Last Price

US$148.13

Market Cap

US$69.0b

7D

0.5%

1Y

-33.7%

Updated

28 Nov, 2022

Data

Company Financials +
ZTS fundamental analysis
Snowflake Score
Valuation3/6
Future Growth3/6
Past Performance2/6
Financial Health5/6
Dividends4/6

ZTS Stock Overview

Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally.

Zoetis Inc. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Zoetis
Historical stock prices
Current Share PriceUS$148.13
52 Week HighUS$249.27
52 Week LowUS$124.15
Beta0.74
1 Month Change-3.36%
3 Month Change-5.70%
1 Year Change-33.74%
3 Year Change23.53%
5 Year Change108.58%
Change since IPO377.69%

Recent News & Updates

Estimating The Fair Value Of Zoetis Inc. (NYSE:ZTS)

Nov 20
Estimating The Fair Value Of Zoetis Inc. (NYSE:ZTS)

Zoetis' Q3 Earnings: Supply Issues Putting A Dent On Growth

Nov 08

Zoetis Q3 2022 Earnings Preview

Nov 02

Recent updates

Estimating The Fair Value Of Zoetis Inc. (NYSE:ZTS)

Nov 20
Estimating The Fair Value Of Zoetis Inc. (NYSE:ZTS)

Does Zoetis (NYSE:ZTS) Deserve A Spot On Your Watchlist?

Nov 02
Does Zoetis (NYSE:ZTS) Deserve A Spot On Your Watchlist?

Is Zoetis (NYSE:ZTS) Using Too Much Debt?

Sep 15
Is Zoetis (NYSE:ZTS) Using Too Much Debt?

Are Investors Undervaluing Zoetis Inc. (NYSE:ZTS) By 21%?

Aug 19
Are Investors Undervaluing Zoetis Inc. (NYSE:ZTS) By 21%?

Here's Why We Think Zoetis (NYSE:ZTS) Is Well Worth Watching

Jul 04
Here's Why We Think Zoetis (NYSE:ZTS) Is Well Worth Watching

Is Zoetis (NYSE:ZTS) Using Too Much Debt?

Jun 17
Is Zoetis (NYSE:ZTS) Using Too Much Debt?

An Intrinsic Calculation For Zoetis Inc. (NYSE:ZTS) Suggests It's 21% Undervalued

May 17
An Intrinsic Calculation For Zoetis Inc. (NYSE:ZTS) Suggests It's 21% Undervalued

Here's Why I Think Zoetis (NYSE:ZTS) Might Deserve Your Attention Today

Mar 26
Here's Why I Think Zoetis (NYSE:ZTS) Might Deserve Your Attention Today

Estimating The Fair Value Of Zoetis Inc. (NYSE:ZTS)

Feb 09
Estimating The Fair Value Of Zoetis Inc. (NYSE:ZTS)

If You Like EPS Growth Then Check Out Zoetis (NYSE:ZTS) Before It's Too Late

Dec 23
If You Like EPS Growth Then Check Out Zoetis (NYSE:ZTS) Before It's Too Late

Zoetis (NYSE:ZTS) Seems To Use Debt Rather Sparingly

Dec 08
Zoetis (NYSE:ZTS) Seems To Use Debt Rather Sparingly

Calculating The Intrinsic Value Of Zoetis Inc. (NYSE:ZTS)

Nov 10
Calculating The Intrinsic Value Of Zoetis Inc. (NYSE:ZTS)

With EPS Growth And More, Zoetis (NYSE:ZTS) Is Interesting

Sep 24
With EPS Growth And More, Zoetis (NYSE:ZTS) Is Interesting

Is Zoetis (NYSE:ZTS) A Risky Investment?

Sep 09
Is Zoetis (NYSE:ZTS) A Risky Investment?

A Look At The Fair Value Of Zoetis Inc. (NYSE:ZTS)

Aug 10
A Look At The Fair Value Of Zoetis Inc. (NYSE:ZTS)

I Built A List Of Growing Companies And Zoetis (NYSE:ZTS) Made The Cut

Jun 23
I Built A List Of Growing Companies And Zoetis (NYSE:ZTS) Made The Cut

We Think Zoetis (NYSE:ZTS) Can Stay On Top Of Its Debt

Jun 08
We Think Zoetis (NYSE:ZTS) Can Stay On Top Of Its Debt

Shareholder Returns

ZTSUS PharmaceuticalsUS Market
7D0.5%1.6%1.3%
1Y-33.7%9.9%-18.5%

Return vs Industry: ZTS underperformed the US Pharmaceuticals industry which returned 9.9% over the past year.

Return vs Market: ZTS underperformed the US Market which returned -18.5% over the past year.

Price Volatility

Is ZTS's price volatile compared to industry and market?
ZTS volatility
ZTS Average Weekly Movement5.5%
Pharmaceuticals Industry Average Movement11.0%
Market Average Movement7.4%
10% most volatile stocks in US Market15.6%
10% least volatile stocks in US Market3.3%

Stable Share Price: ZTS is not significantly more volatile than the rest of US stocks over the past 3 months, typically moving +/- 6% a week.

Volatility Over Time: ZTS's weekly volatility (6%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
195212,100Kristin Peckhttps://www.zoetis.com

Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. The company also offers vaccines, which are biological preparations to prevent diseases of the respiratory, gastrointestinal, and reproductive tracts or induce a specific immune response; anti-infectives that prevent, kill, or slow the growth of bacteria, fungi, or protozoa; and parasiticides that prevent or eliminate external and internal parasites, which include fleas, ticks, and worms.

Zoetis Inc. Fundamentals Summary

How do Zoetis's earnings and revenue compare to its market cap?
ZTS fundamental statistics
Market CapUS$69.04b
Earnings (TTM)US$2.07b
Revenue (TTM)US$8.01b

33.4x

P/E Ratio

8.6x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
ZTS income statement (TTM)
RevenueUS$8.01b
Cost of RevenueUS$2.40b
Gross ProfitUS$5.61b
Other ExpensesUS$3.55b
EarningsUS$2.07b

Last Reported Earnings

Sep 30, 2022

Next Earnings Date

n/a

Earnings per share (EPS)4.43
Gross Margin70.09%
Net Profit Margin25.81%
Debt/Equity Ratio141.5%

How did ZTS perform over the long term?

See historical performance and comparison

Dividends

0.9%

Current Dividend Yield

28%

Payout Ratio